-
Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 52-Week Low After Analyst Downgrade
来源: Buzz FX / 10 1月 2025 12:51:15 America/Chicago
Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 52-Week Low After Analyst Downgrade Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN - Get Free Report ) reached a new 52-w
Read more...